Verastem (VSTM) Net Shares Issued and Repurchased (2012 - 2026)
Powered by 
Analysis
Verastem (VSTM) Net Shares Issued and Repurchased (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | Verastem | 815.95 Mn | 679.59 Mn | 36.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 373,000.00 |
| Dec 31, 2025 | 2.59 Mn |
| Mar 31, 2025 | 38,323.00 |
| Dec 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 603,330.00 |
| Dec 31, 2023 | 1.84 Mn |
| Mar 31, 2023 | 9.93 Mn |
| Dec 31, 2022 | 22.10 Mn |
| Mar 31, 2022 | 330,163.00 |
| Dec 31, 2021 | 22.10 Mn |
| Mar 31, 2021 | 801,659.00 |
| Dec 31, 2020 | 21.73 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Dec 31, 2019 | 19.73 Mn |
| Mar 31, 2019 | 2.23 Mn |
| Dec 31, 2018 | 12.10 Mn |
| Mar 31, 2018 | 582,500.00 |
| Dec 31, 2017 | 10.68 Mn |
| Mar 31, 2017 | 1.66 Mn |
| Dec 31, 2016 | 7.87 Mn |